CN100542570C - A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis - Google Patents

A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis Download PDF

Info

Publication number
CN100542570C
CN100542570C CNB2005100989274A CN200510098927A CN100542570C CN 100542570 C CN100542570 C CN 100542570C CN B2005100989274 A CNB2005100989274 A CN B2005100989274A CN 200510098927 A CN200510098927 A CN 200510098927A CN 100542570 C CN100542570 C CN 100542570C
Authority
CN
China
Prior art keywords
parts
traumatic injury
radix
pain
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100989274A
Other languages
Chinese (zh)
Other versions
CN1739701A (en
Inventor
王浩贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100989274A priority Critical patent/CN100542570C/en
Publication of CN1739701A publication Critical patent/CN1739701A/en
Application granted granted Critical
Publication of CN100542570C publication Critical patent/CN100542570C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis, is that 75% ethanol is formed by Caulis pothi scandentis, Radix Allophylli Viridis, Radix araliae armatae, Radix Cinnamomi Camphorae, Rhizoma Panacis japonici, Ramulus et Folium Claoxyli, Cortex Cinnamomi Burmannii, concentration; Make according to a certain weight ratio; Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively to rheumatalgia, traumatic injury bones and muscles pain, treating swelling and pain by traumatic injury, traumatic injury, rheumatism bones and muscles pain, rheumatic arthritis, wound stasis of blood pain, rheumatism waist leg joint pain, blood stasis swell and ache, the curative effect of disease of soft tissue contusion, articular sprain is definite, the course of treatment is shorter, and effect is better.

Description

A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
Technical field:
The present invention relates to a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis.
Choice of drug Caulis pothi scandentis of the present invention, Radix Allophylli Viridis, Radix araliae armatae, Radix Cinnamomi Camphorae, Rhizoma Panacis japonici, Ramulus et Folium Claoxyli, Cortex Cinnamomi Burmannii, ethanol (concentration is 75%) are formed; Wherein select Caulis pothi scandentis for use: have relaxing muscles and tendons and activating QI and blood in the collateral, reunion of bone, dissipating blood stasis for subsidence of swelling, expelling wind and removing dampness; Dispelling the wind and dampness pathogens pain, traumatic injury, lumbago and skelalgia.Select Radix Allophylli Viridis for use: have easing joint movement, removing blood stasis and activating blood flow; Control traumatic injury, rheumatic arthralgia.Select Radix araliae armatae for use: have dissipating blood stasis for subsidence of swelling, expelling wind and removing dampness; Control traumatic injury, rheumatalgia.Select Radix Cinnamomi Camphorae for use: have expelling wind and removing dampness, removing blood stasis and activating blood flow; The dispelling the wind and dampness pathogens arthralgia, traumatic injury, bones and muscles pain.Select Rhizoma Panacis japonici for use: have removing blood stasis and activating blood flow; Control traumatic injury, bones and muscles pain.Select Ramulus et Folium Claoxyli for use: have expelling wind and removing dampness, eliminating stasis to stop pain; Dispelling the wind and dampness pathogens arthritis, wound stasis of blood pain.Select Cortex Cinnamomi Burmannii for use: have cold expelling, the meridian dredging, expelling wind and removing dampness.Dispelling the wind and dampness pathogens arthritis pain, traumatic injury is sprained.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating that rheumatalgia, traumatic injury bones and muscles pain, treating swelling and pain by traumatic injury, traumatic injury, rheumatism bones and muscles pain, rheumatic arthritis, wound stasis of blood pain, rheumatism waist leg joint pain, blood stasis swell and ache, the curative effect of disease of soft tissue contusion, articular sprain is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
1-16 parts of Caulis pothi scandentis, 1-10 parts of Radix Allophylli Viridiss, 1-12 parts of Radix araliae armatae, 1-12 parts of Radix Cinnamomi Camphoraes, 1-12 parts of Rhizoma Panacis japonici, Ramulus et Folium Claoxyli: 1-8 parts, 1-10 parts of Cortex Cinnamomi Burmanniis, 30-260 parts of ethanol (concentration is 75%).
Optimization formula of the present invention is:
14 parts of Caulis pothi scandentis, 8 parts of Radix Allophylli Viridiss, 10 parts of Radix araliae armatae, 10 parts of Radix Cinnamomi Camphoraes, Rhizoma Panacis japonici 10,6 parts of Ramulus et Folium Claoxyli, 8 parts of Cortex Cinnamomi Burmanniis, 220 parts of ethanol (concentration is 75%).
A kind of Caulis pothi scandentis medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment rheumatalgia, traumatic injury bones and muscles pain, treating swelling and pain by traumatic injury, traumatic injury, rheumatism bones and muscles pain, rheumatic arthritis, wound stasis of blood pain, rheumatism waist leg joint pain, blood stasis swell and ache, the disease of soft tissue contusion, articular sprain; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares a kind of Caulis pothi scandentis medicine for external use of better efficacy with existing similar medicine for external use curative effect.A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis of the present invention was once done a large amount of clinical trials in early stage, inferior between 1998-2005 years to over one hundred example on the patient treatment case, comprise be used for the treatment of that rheumatalgia, traumatic injury bones and muscles pain, treating swelling and pain by traumatic injury, traumatic injury, rheumatism bones and muscles pain, rheumatic arthritis, wound stasis of blood pain, rheumatism waist leg joint pain, blood stasis swell and ache, the disease of soft tissue contusion, articular sprain, do not see untoward reaction during the treatment.Total effective rate is more than 77%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rubs affected part with the hands with the palm of the hand, and affected part is rubbed with the hands to generating heat for good every day 3-6 times.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis provided by the present invention is made up of the component of following parts by weight; 1-16 parts of Caulis pothi scandentis, 1-10 parts of Radix Allophylli Viridiss, 1-12 parts of Radix araliae armatae, 1-12 parts of Radix Cinnamomi Camphoraes, 1-12 parts of Rhizoma Panacis japonici, Ramulus et Folium Claoxyli: 1-8 parts, 1-10 parts of Cortex Cinnamomi Burmanniis, 30-260 parts of ethanol (concentration is 75%).
Embodiment 2:
Optimization formula of the present invention is:
14 parts of Caulis pothi scandentis, 8 parts of Radix Allophylli Viridiss, 10 parts of Radix araliae armatae, 10 parts of Radix Cinnamomi Camphoraes, Rhizoma Panacis japonici 10,6 parts of Ramulus et Folium Claoxyli, 8 parts of Cortex Cinnamomi Burmanniis, 220 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Caulis pothi scandentis, Radix Allophylli Viridis, Radix araliae armatae, Radix Cinnamomi Camphorae, Rhizoma Panacis japonici, Ramulus et Folium Claoxyli, Cortex Cinnamomi Burmannii, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.

Claims (2)

1, a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis is characterized in that: formed through soak with ethanol by following medicine materials in portions by weight: 1-16 parts of Caulis pothi scandentis, 1-10 parts of Radix Allophylli Viridiss, 1-12 parts of Radix araliae armatae, 1-12 parts of Radix Cinnamomi Camphoraes, 1-12 parts of Rhizoma Panacis japonici, Ramulus et Folium Claoxyli: 1-8 parts, 1-10 parts of Cortex Cinnamomi Burmanniis, concentration are 30-260 parts of 75% ethanol.
2, a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis according to claim 1 is characterized in that: formed through soak with ethanol by following medicine materials in portions by weight: 14 parts of Caulis pothi scandentis, 8 parts of Radix Allophylli Viridiss, 10 parts of Radix araliae armatae, 10 parts of Radix Cinnamomi Camphoraes, Rhizoma Panacis japonici 10,6 parts of Ramulus et Folium Claoxyli, 8 parts of Cortex Cinnamomi Burmanniis, concentration are 220 parts of 75% ethanol.
CNB2005100989274A 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis Expired - Fee Related CN100542570C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100989274A CN100542570C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100989274A CN100542570C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Publications (2)

Publication Number Publication Date
CN1739701A CN1739701A (en) 2006-03-01
CN100542570C true CN100542570C (en) 2009-09-23

Family

ID=36092326

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100989274A Expired - Fee Related CN100542570C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Country Status (1)

Country Link
CN (1) CN100542570C (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
万康精治疗急性扭挫伤/肩周炎等病症300例临床观察. 陈业光等.中成药,第19卷第10期. 1997
万康精治疗急性扭挫伤/肩周炎等病症300例临床观察. 陈业光等.中成药,第19卷第10期. 1997 *
跌打损伤药的选用. 陈峥嵘等.家庭医药,第3期. 2005
跌打损伤药的选用. 陈峥嵘等.家庭医药,第3期. 2005 *

Also Published As

Publication number Publication date
CN1739701A (en) 2006-03-01

Similar Documents

Publication Publication Date Title
CN1739620A (en) Externally applied for dispelling wind and dredging meridian passage
CN100506253C (en) Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls
CN100551418C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN100420473C (en) Externally applied medicine of dunn tongoloa root
CN100551415C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN100542570C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN100540020C (en) A kind of Flos Carthami medicine for external use
CN100420476C (en) Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls
CN100518784C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN100542549C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1739624A (en) Externally applied medicine of aizoon stonecrop root
CN100531780C (en) Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae
CN100518778C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN1814232B (en) Wind-repellent collateral-flow-activating pain-relieving medicine of herba cissampeloris pareirae
CN100518791C (en) Externally applied medicine of traumatic injury, rheumatic arthralgiaf
CN100534475C (en) Externally applied medicine of sequin lobelia
CN100534512C (en) Externally applied medicine of Yunan camptandra root
CN100420462C (en) Externally applied medicine of avicenna's pricklyash root
CN100551406C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1814213B (en) Wind-repellent pain-relieving medicine containing ardisia gigantifolia stapf
CN1739644A (en) Externally applied medicine of fortune silene herb
CN1739636A (en) Externally applied medicine of Chinese tinospora stem
CN100420474C (en) Collateral-flow-activating pain-relieving medicine of Radix Tongoloae Dunnii
CN1739646A (en) Externally applied medicine of thickleaf croton root
CN1751709A (en) External use medicine for treating traumatic injury

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090923